FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)


57868 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
Gleason histologic pattern 2 (qualifier value) Preferred (foundation metadata concept)
Gleason histologic pattern 3 Preferred (foundation metadata concept)
Gleason histologic pattern 3 (qualifier value) Preferred (foundation metadata concept)
Gleason histologic pattern 4 Preferred (foundation metadata concept)
Gleason histologic pattern 4 (qualifier value) Preferred (foundation metadata concept)
Gleason histologic pattern 5 Preferred (foundation metadata concept)
Gleason histologic pattern 5 (qualifier value) Preferred (foundation metadata concept)
Glecaprevir Preferred (foundation metadata concept)
Glecaprevir (substance) Preferred (foundation metadata concept)
Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet Preferred (foundation metadata concept)
Glecaprevir and pibrentasvir only product Preferred (foundation metadata concept)
Glenohumeral joint Acceptable (foundation metadata concept)
Glenohumeral joint structure Preferred (foundation metadata concept)
Glenohumeral joint structure (body structure) Preferred (foundation metadata concept)
Glenoid labrum tear Preferred (foundation metadata concept)
Glenoid labrum tear (disorder) Preferred (foundation metadata concept)
Glial tumor of brain Preferred (foundation metadata concept)
Glial tumor of brain (disorder) Preferred (foundation metadata concept)
Gliclazide Preferred (foundation metadata concept)
Gliclazide (substance) Preferred (foundation metadata concept)
Gliclazide 30 mg prolonged-release oral tablet Preferred (foundation metadata concept)
Gliclazide 60 mg prolonged-release oral tablet Preferred (foundation metadata concept)
Gliclazide 80 mg oral tablet Preferred (foundation metadata concept)
Gliclazide only product Preferred (foundation metadata concept)
Glioblastoma Preferred (foundation metadata concept)
Glioblastoma (morphologic abnormality) Preferred (foundation metadata concept)
Glioblastoma multiforme Preferred (foundation metadata concept)
Glioblastoma multiforme Acceptable (foundation metadata concept)
Glioblastoma multiforme (disorder) Preferred (foundation metadata concept)
Glioma Preferred (foundation metadata concept)
Glioma (morphologic abnormality) Preferred (foundation metadata concept)
Glioma of brainstem Preferred (foundation metadata concept)
Glioma of brainstem (disorder) Preferred (foundation metadata concept)
Glioma, malignant Acceptable (foundation metadata concept)
Glioma, malignant (morphologic abnormality) Preferred (foundation metadata concept)
Globe finding Preferred (foundation metadata concept)
Globe finding (finding) Preferred (foundation metadata concept)
Globe observation Acceptable (foundation metadata concept)
Globin abnormality Acceptable (foundation metadata concept)
Globulin measurement Preferred (foundation metadata concept)
Globulin measurement (procedure) Preferred (foundation metadata concept)
Globus hystericus Acceptable (foundation metadata concept)
Globus pharyngeus Acceptable (foundation metadata concept)
Globus sensation Acceptable (foundation metadata concept)
Glomerular mesangium Acceptable (foundation metadata concept)
Glomerulonephritis Preferred (foundation metadata concept)
Glomerulonephritis (disorder) Preferred (foundation metadata concept)
Glomerulosclerosis Preferred (foundation metadata concept)
Glomerulosclerosis (morphologic abnormality) Preferred (foundation metadata concept)
Glomerulus Acceptable (foundation metadata concept)
Glomerulus structure Preferred (foundation metadata concept)
Glomerulus structure (body structure) Preferred (foundation metadata concept)
Glossalgia Acceptable (foundation metadata concept)
Glossitis Preferred (foundation metadata concept)
Glossitis (disorder) Preferred (foundation metadata concept)
Glossodynia Preferred (foundation metadata concept)
Glossodynia (disorder) Preferred (foundation metadata concept)
Glossopyrosis Preferred (foundation metadata concept)
Glossopyrosis (disorder) Preferred (foundation metadata concept)
Glottis Acceptable (foundation metadata concept)
Glottis structure Preferred (foundation metadata concept)
Glottis structure (body structure) Preferred (foundation metadata concept)
Glucagon Preferred (foundation metadata concept)
Glucagon (substance) Preferred (foundation metadata concept)
Glucagon 5 mg/mL solution for injection Preferred (foundation metadata concept)
Glucagon hydrochloride Preferred (foundation metadata concept)
Glucagon hydrochloride (substance) Preferred (foundation metadata concept)
Glucagon hydrochloride 1 mg powder for solution for injection vial Preferred (foundation metadata concept)
Glucagon only product Preferred (foundation metadata concept)
Glucan 1,4-alpha-glucosidase Preferred (foundation metadata concept)
Glucan 1,4-alpha-glucosidase (substance) Preferred (foundation metadata concept)
Glucoamylase Acceptable (foundation metadata concept)
Glucocorticoid Preferred (foundation metadata concept)
Glucocorticoid (substance) Preferred (foundation metadata concept)
Glucoinvertase Acceptable (foundation metadata concept)
Glucose Preferred (foundation metadata concept)
Glucose (substance) Preferred (foundation metadata concept)
Glucose 100 mg/mL solution for injection Preferred (foundation metadata concept)
Glucose 13.5 g and potassium chloride 1.5 g and sodium chloride 2.6 g and sodium citrate 2.9 g powder for oral solution sachet Preferred (foundation metadata concept)
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection Preferred (foundation metadata concept)
Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection Preferred (foundation metadata concept)
Glucose 50 mg/mL solution for injection Preferred (foundation metadata concept)
Glucose 500 mg/mL solution for injection Preferred (foundation metadata concept)
Glucose 75 mg/mL and lidocaine hydrochloride 50 mg/mL solution for injection Preferred (foundation metadata concept)
Glucose 8 g and potassium chloride 300 mg and sodium bicarbonate 300 mg and sodium chloride 200 mg powder for oral solution sachet Preferred (foundation metadata concept)
Glucose and sodium chloride only product Preferred (foundation metadata concept)
Glucose challenge test Acceptable (foundation metadata concept)
Glucose measurement, blood Preferred (foundation metadata concept)
Glucose measurement, blood (procedure) Preferred (foundation metadata concept)
Glucose measurement, urine Preferred (foundation metadata concept)
Glucose measurement, urine (procedure) Preferred (foundation metadata concept)
Glucose only product Preferred (foundation metadata concept)
Glucose oxidase Preferred (foundation metadata concept)
Glucose oxidase (substance) Preferred (foundation metadata concept)
Glucose oxyhydrase Acceptable (foundation metadata concept)
Glucose tolerance test Preferred (foundation metadata concept)
Glucose tolerance test (procedure) Preferred (foundation metadata concept)
Glucose tolerance test outside reference range Preferred (foundation metadata concept)
Glucose tolerance test outside reference range (finding) Preferred (foundation metadata concept)
Glucosidase Preferred (foundation metadata concept)
Glucosidase (substance) Preferred (foundation metadata concept)

Start Previous Page 216 of 579 Next End


Reference Sets

Reference set descriptor

Back to Start